A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy
B. Wu, S. Tapadar, Z. Ruan, C. Sun, R. Arnold, A. Johnston, J. Olugbami, U. Arunsi, D. Gaul, J. Petros, T. Kobayashi, D. G. Duda, A. K. Oyelere
This paper identifies a novel HDAC inhibitor, STR-V-53, that effectively targets HCC and enhances immunotherapy responses in mouse models.
bioRxiv · Mar 27, 2024Cancer Biology